Found: 8
Select item for more details and to access through your institution.
BiDil raises questions about race as a marker.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 8, p. 615, doi. 10.1038/nrd1812
- By:
- Publication type:
- Article
First drug approval for racial group.
- Published in:
- Chemistry & Industry, 2005, n. 13, p. 6
- By:
- Publication type:
- Article
Black Drugs, White Drugs.
- Published in:
- Boston Review, 2019, v. 44, n. 2, p. 27
- By:
- Publication type:
- Article
New heart-failure therapy takes race into account.
- Published in:
- American Journal of Health-System Pharmacy, 2005, v. 62, n. 17, p. 1745, doi. 10.2146/news050016
- By:
- Publication type:
- Article
Epistemic Trafficking: On the Concept of Race-Specific Medicine.
- Published in:
- English Studies in Canada, 2010, v. 36, n. 1, p. 127, doi. 10.1353/esc.2010.0003
- By:
- Publication type:
- Article
BiDil flops.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 3, p. 252, doi. 10.1038/nbt0308-252b
- By:
- Publication type:
- Article
NitroMed Ties Gene Biomarkers to BiDil Benefit.
- Published in:
- Bio-IT World, 2006, v. 5, n. 3, p. 21
- By:
- Publication type:
- Article
The Race Prescription Card.
- Published in:
- Bio-IT World, 2005, v. 4, n. 1, p. 4
- By:
- Publication type:
- Article